#AutismTechnology: Neurotech International to reveal details of autism trial
 | Neurotech International to reveal details of autism trial Proactive Investors Australia Neurotech International Ltd (ASX:NTI) has been granted a trading halt by the ASX this morning, pending a progress update on the independent U.S. clinical trial of Mente Autism. Mente Autism is a clinical-quality EEG device that uses neurofeedback ... |
What do you think of this story? Please share your comments below.
Post a Comment